Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunction

Age-related cardiac fibrosis contributes to the development of heart failure with preserved ejection fraction which lacks ideal treatment. Transient receptor potential ankyrin 1 (TRPA1) is an oxidative stress sensor and could attenuate age-related pathologies in invertebrates. The present study aime...

Full description

Bibliographic Details
Main Authors: Shuangtao Ma, Donna H. Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473441/?tool=EBI
_version_ 1811267427160293376
author Shuangtao Ma
Donna H. Wang
author_facet Shuangtao Ma
Donna H. Wang
author_sort Shuangtao Ma
collection DOAJ
description Age-related cardiac fibrosis contributes to the development of heart failure with preserved ejection fraction which lacks ideal treatment. Transient receptor potential ankyrin 1 (TRPA1) is an oxidative stress sensor and could attenuate age-related pathologies in invertebrates. The present study aimed to test whether TRPA1 plays a role in age-related cardiac remodeling and dysfunction. The cardiac function and pathology of 12-week-old (young) and 52-week-old (older) Trpa1-/- mice and wild-type (WT) littermates were evaluated by echocardiography and histologic analyses. The expression levels of 84 fibrosis-related genes in the heart were measured by quantitative polymerase chain reaction array. Young Trpa1-/- and WT mice had similar left ventricular wall thickness, volume, and systolic and diastolic function. Older Trpa1-/- mice had significantly increased left ventricular internal diameter and volume and impaired systolic (lower left ventricular ejection fraction) and diastolic (higher E/A ratio and isovolumetric relaxation time) functions compared with older WT mice (P<0.05 or P<0.01). Importantly, older Trpa1-/- mice had enhanced cardiac fibrosis than older WT mice (P<0.05) while the two strains had similar degree of cardiac hypertrophy. Among the 84 fibrosis-related genes, Acta2, Inhbe, Ifng, and Ccl11 were significantly upregulated, while Timp3, Stat6, and Ilk were significantly downregulated in the heart of older Trpa1-/- mice compared with older WT mice. Taken together, we found that knocking out Trpa1 accelerated age-related myocardial fibrosis, ventricular dilation, and cardiac dysfunction. These findings suggest that TRPA1 may become a therapeutic target for preventing and/or treating cardiac fibrosis and heart failure with preserved ejection fraction in the elderly.
first_indexed 2024-04-12T21:02:21Z
format Article
id doaj.art-4d0118d123674b8d9a26df81a0f27cc7
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T21:02:21Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4d0118d123674b8d9a26df81a0f27cc72022-12-22T03:16:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01179Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunctionShuangtao MaDonna H. WangAge-related cardiac fibrosis contributes to the development of heart failure with preserved ejection fraction which lacks ideal treatment. Transient receptor potential ankyrin 1 (TRPA1) is an oxidative stress sensor and could attenuate age-related pathologies in invertebrates. The present study aimed to test whether TRPA1 plays a role in age-related cardiac remodeling and dysfunction. The cardiac function and pathology of 12-week-old (young) and 52-week-old (older) Trpa1-/- mice and wild-type (WT) littermates were evaluated by echocardiography and histologic analyses. The expression levels of 84 fibrosis-related genes in the heart were measured by quantitative polymerase chain reaction array. Young Trpa1-/- and WT mice had similar left ventricular wall thickness, volume, and systolic and diastolic function. Older Trpa1-/- mice had significantly increased left ventricular internal diameter and volume and impaired systolic (lower left ventricular ejection fraction) and diastolic (higher E/A ratio and isovolumetric relaxation time) functions compared with older WT mice (P<0.05 or P<0.01). Importantly, older Trpa1-/- mice had enhanced cardiac fibrosis than older WT mice (P<0.05) while the two strains had similar degree of cardiac hypertrophy. Among the 84 fibrosis-related genes, Acta2, Inhbe, Ifng, and Ccl11 were significantly upregulated, while Timp3, Stat6, and Ilk were significantly downregulated in the heart of older Trpa1-/- mice compared with older WT mice. Taken together, we found that knocking out Trpa1 accelerated age-related myocardial fibrosis, ventricular dilation, and cardiac dysfunction. These findings suggest that TRPA1 may become a therapeutic target for preventing and/or treating cardiac fibrosis and heart failure with preserved ejection fraction in the elderly.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473441/?tool=EBI
spellingShingle Shuangtao Ma
Donna H. Wang
Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunction
PLoS ONE
title Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunction
title_full Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunction
title_fullStr Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunction
title_full_unstemmed Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunction
title_short Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunction
title_sort knockout of trpa1 accelerates age related cardiac fibrosis and dysfunction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473441/?tool=EBI
work_keys_str_mv AT shuangtaoma knockoutoftrpa1acceleratesagerelatedcardiacfibrosisanddysfunction
AT donnahwang knockoutoftrpa1acceleratesagerelatedcardiacfibrosisanddysfunction